PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
PMGC's price to sales ratio was 3.8× on Nov 11, 2026, against 487.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.8× | −37.6 |
| 2025 | Jan 31, 2025 | 41.4× | −14.0 |
| 2024 | Dec 31, 2024 | 55.5× | – |
See a number that looks wrong?